Anti-AAV8 + AAV9 antibody [HL2372] - BSA and Azide free
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Mouse Recombinant Monoclonal AAV8 antibody. Carrier free. Suitable for I-ELISA, Dot and reacts with Recombinant fragment - Adeno-associated virus - 8, Recombinant fragment - Adeno-associated virus 9 samples.
View Alternative Names
Adeno-associated virus - 8
- Dot
Supplier Data
Dot Blot - Anti-AAV8 + AAV9 antibody [HL2372] - BSA and Azide free (AB315822)
This data was developed using ab315821, the same antibody clone in a different buffer formulation.
Dot blot analysis of AAV8 + AAV9 using ab315821 at 1 : 2000 (0.5 ug/ml) followed by a Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1 : 5000 dilution.
Dot blot was performed using 1 ng of each capsid loaded per well.
Anti-AAV9 antibody [HL2368] (ab315818) (1 : 2000), Anti-AAV9 antibody [HL2370] (ab315820) (1 : 2000), Anti-AAV9 antibody [HL2374] (ab315823) (1 : 2000), and Anti-AAV9 antibody [HL2374-IgG1] - BSA and Azide free (ab315826) (1 : 2000) specifically recognize AAV9 capsid.
Anti-AAV8 + AAV3B antibody [HL2383] (ab315827) (1 : 2000), and Anti-AAV8 + AAV3B antibody [HL2383-IgG1] (ab315829) (1 : 2000) specifically recognize AAV8/3B capsid.
Anti-AAV8 + AAV9 antibody [HL2372] (ab315821) (1 : 2000) specifically recognizes AAV8/9 capsid.
Anti-AAV5 antibody [HL2476] (ab315831) (1 : 2000) specifically recognizes AAV5 capsid.
true
Exposure time: 8min
Reactivity data
Product details
ab315822 is the carrier-free version of ab315821.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AAV8 and AAV9 are versatile vectors that carry therapeutic genes to specific cells without integrating into the host genome. They are not known to cause any human disease which makes them attractive in clinical applications. AAV9 for instance can cross the blood-brain barrier allowing it to reach neurological targets efficiently. Although these vectors do not function as part of a larger biological complex their ability to encapsulate expression cassettes distinguishes them from other viral vectors enhancing their use in targeting diverse genetic disorders.
Pathways
AAV8 and AAV9 are critical tools in gene transfer technology leveraging various mechanisms such as endocytosis to enter target cells. They primarily participate in pathways involving the transduction of encoded genetic material avoiding integration into the host DNA. AAV8 has displayed efficient interaction with hepatic pathways while AAV9 is linked with neuronal pathways due to its ability to cross the blood-brain barrier. These serotypes potentially interact with specific cellular receptors or transport proteins during their entry and trafficking within host cells facilitating targeted gene delivery.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com